Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WI/Madison
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Madison, WI

Studies commonly pay $75 to $4,500 per completed study

535 clinical trials are currently recruiting participants within 30 miles of Madison. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

535studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Madison right now

Top 25 of 535 recruiting studies, sorted by proximity — each links to its official registry page

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
UW Health Comprehensive Program for Bleeding Disorders — Madison, Wisconsin (0.8 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
University of Wisconsin Carbone Cancer Center - University Hospital — Madison, Wisconsin (0.8 mi) · Sponsor: National Cancer Institute (NCI)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Madison, Wisconsin (0.8 mi) · Sponsor: Daiichi Sankyo

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: SWOG Cancer Research Network

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
SSM Health Dean Medical Group ( Site 0106) — Madison, Wisconsin (0.8 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma, Relapsed/Refractory Multiple Myeloma Phase 2 Interventional 100 participants sought
University of Wisconsin - Carbone Cancer Center — Madison, Wisconsin (0.8 mi) · Sponsor: C4 Therapeutics, Inc.

Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework

Congenital Heart Disease N/A Interventional 450 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi) · Sponsor: University of Wisconsin, Madison

Resistant Potato Starch to Alleviate GWI

Gulf War Illness Phase 2 Interventional 52 participants sought
William S. Middleton Memorial Veterans Hospital, Madison, WI — Madison, Wisconsin (0.8 mi) · Sponsor: VA Office of Research and Development

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult, Metastatic Breast Cancer Phase 1 Interventional 392 participants sought
Wisconsin Institute for Medical Research — Madison, Wisconsin (0.8 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University Telemedicine — Madison, Wisconsin (0.8 mi) · Sponsor: Sameek Roychowdhury

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer Phase 3 Interventional 1,000 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: Pfizer

Randomized Trial of SGLT2i in Heart Transplant Recipients

Heart Transplant, Cardiovascular Disease Phase 4 Interventional 200 participants sought
William S. Middleton Memorial Veterans Hospital, Madison, WI — Madison, Wisconsin (0.8 mi) · Sponsor: VA Office of Research and Development

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Madison, Wisconsin (0.8 mi) · Sponsor: AstraZeneca

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi) · Sponsor: Kura Oncology, Inc.

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi) · Sponsor: SWOG Cancer Research Network

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical ( Site 0048) — Madison, Wisconsin (0.8 mi) · Sponsor: Merck Sharp & Dohme LLC

A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

Healthy Volunteers Phase 1 Interventional 10 participants sought
Fortrea Clinical Research Unit Inc. — Madison, Wisconsin (0.8 mi) · Sponsor: Eisai Inc.

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Phase 1 Interventional 272 participants sought
University of Wisconsin Carbone Cancer Center — Madison, Wisconsin (0.8 mi) · Sponsor: Janux Therapeutics
Actively enrolling

Studies you may be able to join near Madison

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Madison

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

UW Health Wisconsin Institutes for Medical Research

★ 4.9
1111 Highland Ave, Madison, WI 53705
(608) 265-3270
"Always greeted promptly and respectfully. Appointment begins right on time. Ample privacy for changing."
— Robin Douthitt, 5★

Center for Health Disparities Research

UW Hospital and Clinics, 600 Highland Ave, MSC 3690, K4, Madison, WI 53792

Fortrea Clinical Trials MSN

★ 2.7
3402 Kinsman Blvd, Madison, WI 53704
(866) 429-3700
"I have participated in studies with Fortrea several times over the years and had built positive relationships with some staff members, which made my …"
— Merrisa M, 1★

UW Cardiovascular Research Center

Wisconsin Institute for Medical Research, 8503, 1111 Highland Ave, Madison, WI 53705

UW Center for Precision Medicine (CPM)

1111 Highland Ave Rm 2700, Madison, WI 53705
(608) 263-7866

Center For Health Systems Research and Analysis

★ 5.0
Warf Office Bldg, 610 Walnut St, Madison, WI 53726
(608) 263-5722

Center for Healthy Minds

★ 4.3
625 W Washington Ave, Madison, WI 53703
(608) 263-6321
"I really love their app. It's been a huge help."
— Abbey Dove, 5★

Covance Clinical Research Unit

★ 3.6
3402 Kinsman Blvd, Madison, WI 53704
(866) 429-3700
"I screened awhile ago It went well. I hear nothing but good about this place. I hope I have better luck next time."
— William, 5★

McArdle Laboratory for Cancer Research

★ 5.0
1111 Highland Ave, Madison, WI 53705
(608) 262-2177

Clinical trials in Madison: what's recruiting

The Madison area currently has 535 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Madison, the most active research areas are:

  • Cancer & Oncology14 studies
  • Heart & Vascular2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Madison, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Madison

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Madison participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Madison pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Madison?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Madison safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Madison, WI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Madison typically complete one or two studies per year.

Paid clinical trials near Madison

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of WI

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts